Literature DB >> 15893752

Regulation of neuronal and glial galectin-1 expression by peripheral and central axotomy of rat primary afferent neurons.

J McGraw1, A D Gaudet, L W Oschipok, T Kadoya, H Horie, J D Steeves, W Tetzlaff, M S Ramer.   

Abstract

Galectin-1 (Gal1) is an endogenously-expressed protein important for the embryonic development of the full complement of primary sensory neurons and their synaptic connections in the spinal cord. Gal1 also promotes axonal regeneration following peripheral nerve injury, but the regulation of Gal1 by axotomy in primary afferent neurons has not yet been examined. Here, we show by immunohistochemistry and in situ hybridization that Gal1 expression is differentially regulated by peripheral nerve injury and by dorsal rhizotomy. Following peripheral nerve injury, the proportion of Gal1-positive DRG neurons was increased. An increase in the proportion of large-diameter DRG neurons immunopositive for Gal1 was paralleled by an increase in the depth of immunoreactivity in the dorsal horn, where Gal1-positive terminals are normally restricted to laminae I and II. Dorsal rhizotomy did not affect the proportions of neurons containing Gal1 mRNA or protein, but did deplete the ipsilateral dorsal horn of Gal1 immunoreactivity, indicating that it is transported centrally by dorsal root axons. Dorsal rhizotomy also resulted in an increase in Gal1 mRNA the nerve peripheral to the PNS-CNS interface (likely within Schwann cells and/or macrophages), and to a lesser extent within deafferented spinal cord regions undergoing Wallerian degeneration. This latter increase was notable in the dorsal columns and along the prior trajectories of myelinated afferents into the deeper dorsal horn. These results show that neuronal and glial expressions of Gal1 are tightly correlated with regenerative success. Thus, the differential expression pattern of Gal1 following peripheral axotomy and dorsal rhizotomy suggests that endogenous Gal1 may be a factor important to the regenerative response of injured axons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893752     DOI: 10.1016/j.expneurol.2005.04.004

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  11 in total

1.  Glycan-dependent binding of galectin-1 to neuropilin-1 promotes axonal regeneration after spinal cord injury.

Authors:  H R Quintá; J M Pasquini; G A Rabinovich; L A Pasquini
Journal:  Cell Death Differ       Date:  2014-02-21       Impact factor: 15.828

2.  Galectin-1 in injured rat spinal cord: implications for macrophage phagocytosis and neural repair.

Authors:  Andrew D Gaudet; David R Sweet; Nicole K Polinski; Zhen Guan; Phillip G Popovich
Journal:  Mol Cell Neurosci       Date:  2014-12-24       Impact factor: 4.314

3.  Galectin-1 Reduces Neuroinflammation via Modulation of Nitric Oxide-Arginase Signaling in HIV-1 Transfected Microglia: a Gold Nanoparticle-Galectin-1 "Nanoplex" a Possible Neurotherapeutic?

Authors:  Ravikumar Aalinkeel; Courtney S Mangum; Eliane Abou-Jaoude; Jessica L Reynolds; Maixian Liu; Karin Sundquist; Neil U Parikh; Lee D Chaves; Manoj J Mammen; Stanley A Schwartz; Supriya D Mahajan
Journal:  J Neuroimmune Pharmacol       Date:  2016-12-27       Impact factor: 4.147

4.  Galectin-1 Contributes to Vascular Remodeling and Blood Flow Recovery After Cerebral Ischemia in Mice.

Authors:  Yin-Hong Cheng; Yi-Fan Jiang; Chuan Qin; Ke Shang; Yuan Yuan; Xian-Jie Wei; Zhe Xu; Xiang Luo; Wei Wang; Wen-Sheng Qu
Journal:  Transl Stroke Res       Date:  2021-05-10       Impact factor: 6.829

5.  Galectin-1 ameliorates perioperative neurocognitive disorders in aged mice.

Authors:  Zhiwen Shen; Hui Xu; Wen Song; Chuwen Hu; Mingyan Guo; Jinfeng Li; Junhua Li
Journal:  CNS Neurosci Ther       Date:  2021-05-04       Impact factor: 5.243

6.  Neurons define non-myelinated axon segments by the regulation of galectin-4-containing axon membrane domains.

Authors:  Natalia Díez-Revuelta; Alonso M Higuero; Silvia Velasco; María Peñas-de-la-Iglesia; Hans-Joachim Gabius; José Abad-Rodríguez
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

7.  Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls.

Authors:  Tainá M Marques; Anouke van Rumund; Ilona B Bruinsma; Hans J C T Wessels; Jolein Gloerich; Rianne A J Esselink; Bastiaan R Bloem; H Bea Kuiperij; Marcel M Verbeek
Journal:  Mol Neurobiol       Date:  2018-11-21       Impact factor: 5.590

8.  Age-dependent transcriptome and proteome following transection of neonatal spinal cord of Monodelphis domestica (South American grey short-tailed opossum).

Authors:  Norman R Saunders; Natassya M Noor; Katarzyna M Dziegielewska; Benjamin J Wheaton; Shane A Liddelow; David L Steer; C Joakim Ek; Mark D Habgood; Matthew J Wakefield; Helen Lindsay; Jessie Truettner; Robert D Miller; A Ian Smith; W Dalton Dietrich
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

Review 9.  Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders.

Authors:  Amila Omeragic; Olanre Kayode; Md Tozammel Hoque; Reina Bendayan
Journal:  Fluids Barriers CNS       Date:  2020-07-10

10.  Animal Galectins and Plant Lectins as Tools for Studies in Neurosciences.

Authors:  João Ronielly Campêlo Araújo; Cauê Barbosa Coelho; Adriana Rolim Campos; Renato de Azevedo Moreira; Ana Cristina de Oliveira Monteiro-Moreira
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.